evaluation of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival white birch pollen allergen challenge double masked, comparison study

Trial Profile

evaluation of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival white birch pollen allergen challenge double masked, comparison study

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Epinastine (Primary)
  • Indications Allergic conjunctivitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2015 Status changed from not yet recruiting to completed as per University Hospital Medical Information Network - Japan.
    • 04 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top